Found 91 matching trials
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer PHASE2 This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided ...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Learn More & Join Trial
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC PHASE2 The goal of this clinical trial is to learn if oral probiotics (Clostridium...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression PHASE2 This is a prospective, open, single-center clinical study of anti-HER2-ADC ...
Show More Location
Ethics Committee of Shanghai Renji Hospital
Learn More & Join Trial
Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial PHASE3 The goal of this multicentre, randomized, double-blind controlled, phase II...
Show More Location
Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Learn More & Join Trial
A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. PHASE2 This study is a single-center, phase II clinical trial. Patients with HER2-...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study PHASE2 This multicenter, Phase II study (RADIANT-BC01) evaluates the efficacy and ...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens PHASE1 This trial is a single center, single arm, open label clinical study aimed ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer PHASE2 The goal of this clinical trial is to learn if the combination of disitamab...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial